These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21730030)

  • 1. Kinetic characterization of rat hepatic uptake of 16 actively transported drugs.
    Yabe Y; Galetin A; Houston JB
    Drug Metab Dispos; 2011 Oct; 39(10):1808-14. PubMed ID: 21730030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
    Poirier A; Funk C; Scherrmann JM; Lavé T
    Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes.
    Jigorel E; Houston JB
    Drug Metab Dispos; 2012 Aug; 40(8):1596-602. PubMed ID: 22593038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model.
    Ménochet K; Kenworthy KE; Houston JB; Galetin A
    J Pharmacol Exp Ther; 2012 Apr; 341(1):2-15. PubMed ID: 22190645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.
    Parker AJ; Houston JB
    Drug Metab Dispos; 2008 Jul; 36(7):1375-84. PubMed ID: 18426953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative use of isolated hepatocytes and hepatic microsomes for cytochrome P450 inhibition studies: transporter-enzyme interplay.
    Brown HS; Wilby AJ; Alder J; Houston JB
    Drug Metab Dispos; 2010 Dec; 38(12):2139-46. PubMed ID: 20847136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
    Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
    Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
    Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.
    Ménochet K; Kenworthy KE; Houston JB; Galetin A
    Drug Metab Dispos; 2012 Sep; 40(9):1744-56. PubMed ID: 22665271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2007 Aug; 35(8):1325-32. PubMed ID: 17470525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo.
    Soars MG; Grime K; Sproston JL; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2007 Jun; 35(6):859-65. PubMed ID: 17344337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional consequences of active hepatic uptake on cytochrome P450 inhibition in rat and human hepatocytes.
    Grime K; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2008 Aug; 36(8):1670-8. PubMed ID: 18474678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of macrolide antibiotics on uptake of digoxin into rat liver.
    Ito S; Nasu R; Tsujimoto M; Murakami H; Ohtani H; Sawada Y
    Biopharm Drug Dispos; 2007 Apr; 28(3):113-23. PubMed ID: 17253595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin.
    Nezasa K; Higaki K; Takeuchi M; Nakano M; Koike M
    Xenobiotica; 2003 Apr; 33(4):379-88. PubMed ID: 12745873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Assessment In Vitro of Transporter and Metabolic Processes in Hepatic Drug Clearance: Use of a Media Loss Approach.
    Harrison J; De Bruyn T; Darwich AS; Houston JB
    Drug Metab Dispos; 2018 Apr; 46(4):405-414. PubMed ID: 29439129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
    Kimoto E; Chupka J; Xiao Y; Bi YA; Duignan DB
    Drug Metab Dispos; 2011 Jan; 39(1):47-53. PubMed ID: 20926619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.